Insider · CIK 0001571480
Doron Blachar
Files at ORA (ORMAT TECHNOLOGIES, INC.). First filing Sep 30, 2025, latest Sep 30, 2025.
In brief
Doron Blachar files SEC Form 4 as CEO at ORA (ORMAT TECHNOLOGIES, INC.). Since Sep 30, 2025, Doron Blachar has reported 0 open-market buys worth $0 and 1 open-market sell worth $1.4M, the latest filed on Sep 30, 2025.
A track record needs three past buys with six months of prices behind them; Doron Blachar has 0, so none is measured yet.
The newest scored trade: sold $1.4M of ORA on Sep 29, 2025, filed Sep 30, 2025, scored 40 (moderate), under a 10b5-1 plan.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ORA: ORMAT TECHNOLOGIES, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | ORMAT TECHNOLOGIES, INC. | $1.4M 14,994 shares | -30% | +54% from low0% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 29, 2025 | ORA ORMAT TECHNOLOGIES, INC. | 14,994 0.02% of outstanding | $1.4M | Sep 29, 2025 | none |
Transactions
Every row this insider has filed, 27 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 21, 2026 | ORA ORMAT TECHNOLOGIES, INC. | MOption exercise Common Stock | +2,252 | $0.00 | $0 | 48,735 | Mar 25, 2026 |
| Mar 21, 2026 | ORA ORMAT TECHNOLOGIES, INC. | MOption exercise Common Stock | +13,999 | $0.00 | $0 | 62,734 | Mar 25, 2026 |
| Mar 21, 2026 | ORA ORMAT TECHNOLOGIES, INC. | MOption exercise Restricted Stock Unitsderivative | -2,252 | $0.00 | $0 | 2,253 | Mar 25, 2026 |
| Mar 21, 2026 | ORA ORMAT TECHNOLOGIES, INC. | AGrant or award Restricted Stock Unitsderivative | -4,667 | $0.00 | $0 | 4,667 | Mar 25, 2026 |
| Mar 1, 2026 | ORA ORMAT TECHNOLOGIES, INC. | MOption exercise Common Stock | +805 | $0.00 | $0 | 36,224 | Mar 3, 2026 |
| Mar 1, 2026 | ORA ORMAT TECHNOLOGIES, INC. | MOption exercise Common Stock | +5,139 | $0.00 | $0 | 41,363 | Mar 3, 2026 |
| Mar 1, 2026 | ORA ORMAT TECHNOLOGIES, INC. | MOption exercise Common Stock | +3,871 | $0.00 | $0 | 45,234 | Mar 3, 2026 |
| Mar 1, 2026 | ORA ORMAT TECHNOLOGIES, INC. | MOption exercise Common Stock | +1,249 | $0.00 | $0 | 46,483 | Mar 3, 2026 |
| Mar 1, 2026 | ORA ORMAT TECHNOLOGIES, INC. | MOption exercise Restricted Stock Unitsderivative | -805 | $0.00 | $0 | 0 | Mar 3, 2026 |
| Mar 1, 2026 | ORA ORMAT TECHNOLOGIES, INC. | MOption exercise Restricted Stock Unitsderivative | -5,139 | $0.00 | $0 | 5,140 | Mar 3, 2026 |
| Mar 1, 2026 | ORA ORMAT TECHNOLOGIES, INC. | MOption exercise Restricted Stock Unitsderivative | -3,871 | $0.00 | $0 | 7,742 | Mar 3, 2026 |
| Mar 1, 2026 | ORA ORMAT TECHNOLOGIES, INC. | MOption exercise Restricted Stock Unitsderivative | -1,249 | $0.00 | $0 | 0 | Mar 3, 2026 |
| Mar 1, 2026 | ORA ORMAT TECHNOLOGIES, INC. | AGrant or award Restricted Stock Unitsderivative | +12,653 | $0.00 | $0 | 12,653 | Mar 3, 2026 |
| Sep 29, 2025 | ORA ORMAT TECHNOLOGIES, INC. | MOption exercise Common Stock10b5-1 | +45,365 | $63.40 | $2.9M | 80,784 | Sep 30, 2025 |
| Sep 29, 2025 | ORA ORMAT TECHNOLOGIES, INC. | DDisposition to issuer Common Stock10b5-1 | -30,371 | $94.71 | $2.9M | 50,413 | Sep 30, 2025 |
| Sep 29, 2025 | ORA ORMAT TECHNOLOGIES, INC. | SOpen-market sale Common Stock10b5-1 | -14,994 | $94.71 | $1.4M | 35,419 | Sep 30, 2025 |
| Sep 29, 2025 | ORA ORMAT TECHNOLOGIES, INC. | MOption exercise Stock Appreciation Rights (SARs)derivative10b5-1 | -45,365 | $0.00 | $0 | 0 | Sep 30, 2025 |
| Mar 21, 2025 | ORA ORMAT TECHNOLOGIES, INC. | MOption exercise Common Stock | +2,252 | $0.00 | $0 | 35,419 | Mar 25, 2025 |
| Mar 21, 2025 | ORA ORMAT TECHNOLOGIES, INC. | MOption exercise Restricted Stock Unitsderivative | -2,252 | $0.00 | $0 | 4,505 | Mar 25, 2025 |
| Mar 1, 2025 | ORA ORMAT TECHNOLOGIES, INC. | MOption exercise Common Stock | +805 | $0.00 | $0 | 24,282 | Mar 4, 2025 |
| Mar 1, 2025 | ORA ORMAT TECHNOLOGIES, INC. | MOption exercise Common Stock | +5,135 | $0.00 | $0 | 29,417 | Mar 4, 2025 |
| Mar 1, 2025 | ORA ORMAT TECHNOLOGIES, INC. | MOption exercise Common Stock | +3,750 | $0.00 | $0 | 33,167 | Mar 4, 2025 |
| Mar 1, 2025 | ORA ORMAT TECHNOLOGIES, INC. | MOption exercise Restricted Stock Unitsderivative | -805 | $0.00 | $0 | 804 | Mar 4, 2025 |
| Mar 1, 2025 | ORA ORMAT TECHNOLOGIES, INC. | MOption exercise Restricted Stock Unitsderivative | -5,135 | $0.00 | $0 | 10,284 | Mar 4, 2025 |
| Mar 1, 2025 | ORA ORMAT TECHNOLOGIES, INC. | MOption exercise Performance Based Unitsderivative | -5,974 | $0.00 | $0 | 0 | Mar 4, 2025 |
| Mar 1, 2025 | ORA ORMAT TECHNOLOGIES, INC. | MOption exercise Restricted Stock Unitsderivative | +1,250 | $0.00 | $0 | 1,250 | Mar 4, 2025 |
| Mar 1, 2025 | ORA ORMAT TECHNOLOGIES, INC. | AGrant or award Restricted Stock Unitsderivative | +11,613 | $0.00 | $0 | 11,613 | Mar 4, 2025 |
Questions about Doron Blachar
Answered from the filings on this page, as of the latest one.
Is Doron Blachar buying or selling?
Not in the last 12 months. Doron Blachar's latest open-market trade on SEC Form 4 was sold $1.4M of ORA on Sep 29, 2025.
How did Doron Blachar's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Doron Blachar has 0.
Where does Doron Blachar file Form 4?
Doron Blachar has filed Form 4 at ORA (ORMAT TECHNOLOGIES, INC.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.